Email Updates

Place quotation marks around exact phrases (e.g. "new york"). Note: Trial names have a space before the number (e.g. HVTN 100).

You are here

Home

Trial Search

Trial Name Prevention Option Phase Start Date Sponsors Countries Population Candidate(s) Status
IPM 056 / CCN019B Multipurpose Prevention Technologies, PrEP I/II June 2022 IPM, NICHD, NIH United States of America Women Dapivirine-Levonorgestrel ring Ongoing
CLIP Ring Microbicides, Multipurpose Prevention Technologies Pre-clinical December 2019 CDC, NIAID Men Islatravir (MK-8591)
CONRAD B17-144 Microbicides, Multipurpose Prevention Technologies II December 2018 Kenya Women TFV/LNG ring, TFV ring Ongoing
CONRAD A15-138/ ENRICH Microbicides, Multipurpose Prevention Technologies I September 2017 CONRAD United States of America, Dominican Republic Men TFV/LNG ring Completed
Population Council #558 Microbicides, Multipurpose Prevention Technologies I May 2014 Population Council United States of America Women PC-1005 gel, HEC gel Completed
CONRAD A18-146 Microbicides, Multipurpose Prevention Technologies I December 2018 CONRAD United States of America Women Elvitegravir (EVG), F/TAF Completed
MTN-044/IPM 053/ CCN019 Microbicides, Multipurpose Prevention Technologies Open Label, I July 2018 United States of America Women Dapivirine-Levonorgestrel ring Completed
DREAM-01 Microbicides, Multipurpose Prevention Technologies I October 2016 NIAID (DAIDS-ES: 12067) United States of America, Malawi Men Ongoing
TRIO Study (Tablets, Rings, and Injectables as Options for women) Microbicides, Multipurpose Prevention Technologies Other November 2014 Bill & Melinda Gates Foundation (OPP1114942) Kenya, South Africa Women Completed
Promoting CSD500 Use Among Women in Established Relationships Male and Female Condoms, Multipurpose Prevention Technologies Open Label March 2017 Ohio State University, Vietnam: Ministry of Health, University of North Carolina, Chapel Hill Vietnam Women, Men Planned
Performance and Safety Trial of an Innovative Female Condom (Wondaleaf®) Male and Female Condoms, Multipurpose Prevention Technologies Open Label August 2015 Clinical Research Centre, Malaysia Twin Catalyst Sdn. Bhd. Malaysia Women, Men Completed
MTN-039 Microbicides, Multipurpose Prevention Technologies Open Label, I December 2019 MTN United States of America Men, Women Elvitegravir (EVG) Ongoing
A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04 Microbicides, Multipurpose Prevention Technologies I November 2013 CONRAD United States of America Women 1% tenofovir gel, HEC gel, tenofovir Completed
MTN 037 Microbicides, Multipurpose Prevention Technologies I June 2018 NIAID (DAIDS-ES: 35122) United States of America Men, Women PC-1005 gel Ongoing
Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of HSV and HIV (VAST) Antibody Related Research, Combination Prevention, Microbicides, Multipurpose Prevention Technologies I January 2016 ZabBio Inc., National Institute of Allergy and Infectious Diseases (NIAID), Boston University, The Miriam Hospital United States of America Women VRC01 Completed
MTN 030/IPM 041 Multipurpose Prevention Technologies I June 2017 IPM United States of America Women Dapivirine Ring, Dapivirine-Levonorgestrel ring Completed
CONRAD 117 Microbicides, Multipurpose Prevention Technologies I February 2013 CONRAD United States of America Women 1% tenofovir gel, FTC, TVF/FTC Completed
CONRAD 120 Microbicides, Multipurpose Prevention Technologies I June 2012 CONRAD United States of America Women 1% tenofovir gel Completed
CSVDoc